Silodosin: A selective α1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference34 articles.
1. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations;J Urol.,2003
2. Benign prostatic hyperplasia: A review and ultrasound classification;Wasserman;Radiol Clin North Am.,2006
3. Benign prostatic hyperplasia [published correction appears in Lancet. 2003;362:496];Thorpe;Lancet,2003
4. Benign prostatic hyperplasia: Etiology, pathophysiology, epidemiology, and natural history;Roehrborn,2007
5. Benign prostatic hyperplasia as a progressive disease: A guide to the risk factors and options for medical management;Emberton;Int J Clin Pract.,2008
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel eco-friendly HPLC method with dual detection modes for versatile quantification of dutasteride and silodosin in pharmaceutical formulation, dissolution testing and spiked human plasma;Microchemical Journal;2024-02
2. State-of-the-art mathematically induced filtration approaches for smart spectrophotometric assessment of silodosin and solifenacin mixture in their new challenging formulation: Multi-tool greenness and whiteness evaluation;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-02
3. Prophylactic A-Blockers for Radiotherapy-Induced Lower Urinary Tract Symptoms in Men with Prostate Cancer: A Phase III Randomized Trial;Cancers;2023-06-30
4. Sustainable and smart HPTLC determination of silodosin and solifenacin using a constructed two illumination source chamber with a smartphone camera as a detector: Comparative study with conventional densitometric scanner;Sustainable Chemistry and Pharmacy;2023-06
5. α1-Adrenergic Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure, and Alzheimer’s Disease;International Journal of Molecular Sciences;2023-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3